- Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.
- Collaboration agreements for oncology candidates were signed between several major pharmaceutical companies.
- A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.
Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.
3 reports, 2 independent
Updated Jul 14
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Recursion expands partnerships with Bayer and Roche, leveraging Nvidia's data processing capabilities.1 source
- A critical strategic collaboration has formed involving Hoffmann-La Roche, Recursion, Recordati, Moderna, Sanofi, and Merck KGaA to diversify pipelines through automated biological research.Sub-event
Recursion expands its strategic alliances to include Bayer, alongside existing partners Sanofi, Roche, and Merck.1 source
Keep exploring
The entities involved
-
Recursion (United States)
company in Salt Lake City, United States
-
BAYER
company in Prague, Czechia
-
Sanofi
French pharmaceutical company
Related events
- Recursion Pharmaceuticals is listed on Nasdaq, and BioCardia, Inc. is a company developing therapeutics in the United States.
- Bayer acquired Monsanto during the acquisition of the original manufacturer.
- A conference involving Gilead Sciences and Bayer was held in Philadelphia on September 10, 2026.
- Matthias Berninger represents Bayer in agreement.